
PhRMA chief plays favorites in singling out Martin Shkreli as a ‘bad actor’; Roche extends antibiotics collaboration
→ PhRMA CEO Steve Ubl enjoys holding up Turing’s Martin Shkreli as an example of the kind of “bad actors” that are giving pharma companies a bad name. The Boston Business Journal noted that Ubl singled out Shkreli in a Q&A with reporters. But what about Marathon CEO and PhRMA board member Jeff Aronin, who finds himself at the center of a tempest over the approval of deflazacort? STAT notes: “Ubl wouldn’t say what kind of companies might get the boot from PhRMA once the membership criteria are revised. But he said the revision process ‘should take weeks not months.’ He also confirmed that while Marathon is still a PhRMA member, it’s possible that after the review it might not be.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.